Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

30576
1
Shimmick Corp Shimmick Corporation Reports Significant Financial Challenges, Net Losses in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

30577
1
NV5 Global, Inc. NV5 Global Reports 5.6% Revenue Growth, Gross Profit Margin Increase in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

30578
1
BridgeBio Pharma, Inc. BridgeBio Pharma Reports Q3 2024 Financial Results, Significant Restructuring, and Milestone Payment Opportunity

Via official filing (AI summary) | over 1 year ago | 0 comments

30579
1
Absci Corp Absci Corporation Reports 129% Revenue Growth in Q3, Net Loss Widens

Via official filing (AI summary) | over 1 year ago | 0 comments

30580
1
Roivant Sciences Ltd. Roivant Sciences Reports Revenue Growth, Increased Expenses, and Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

30581
1
Thoughtworks Holding, Inc. Thoughtworks Reports Decline in Revenue and Net Loss for Q3 and Nine Months of 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

30582
1
TScan Therapeutics, Inc. TScan Therapeutics Reports Decline in Collaboration Revenue, Increased Operating Expenses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

30583
1
Dyne Therapeutics, Inc. Dyne Therapeutics Reports Significant Asset Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

30584
1
FAMILY OFFICE OF AMERICA, INC. Qualis Innovations Reports Significant Financial Improvements, Net Loss Narrows in Latest 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments

30585
1
Maiden Holdings, Ltd. Maiden Holdings Reports Significant Net Loss and Revenue Decline in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

30586
1
SPRUCE BIOSCIENCES, INC. Spruce Biosciences Reports Financial Results, Implements Cost Reduction Measures, and Explores Additional Financing Options

Via official filing (AI summary) | over 1 year ago | 0 comments

30587
1
ASSURED GUARANTY LTD Assured Guaranty Ltd. Reports Mixed Q3 2024 Results, Decline in Revenues and Adjusted Operating Income

Via official filing (AI summary) | over 1 year ago | 0 comments

30588
1
Perimeter Solutions, Inc. Perimeter Solutions Reports 102% Net Sales Growth, Operating Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

30589
1
reAlpha Tech Corp. reAlpha Tech Corp. Reports 475% Revenue Growth, Operating Losses in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

30590
1
Vincerx Pharma, Inc. Vincerx Pharma Reports Significant Decrease in Cash and Cash Equivalents, Operating Expenses, and Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments

30591
1
Lifeward Ltd. LifeWard Ltd. Reports 39% Revenue Growth, Narrowing Losses in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

30592
1
WERNER ENTERPRISES INC Werner Enterprises Reports Decline in Revenue and Net Income for Q3 and Nine Months of 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

30593
1
HERON THERAPEUTICS, INC. /DE/ Heron Therapeutics Reports Improved Revenue and Reduced Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

30594
1
NEVRO CORP Nevro Corp. Reports Decline in Revenue and Profitability for Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

30595
1
FEMASYS INC Femasys Inc. Reports 127% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

30596
1
DZS INC. DZS Inc. Reports 67.8% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

30597
1
UFP TECHNOLOGIES INC UFP Technologies Reports 44% Revenue Growth in Q3 2024, Driven by Medical Market and Strategic Acquisitions

Via official filing (AI summary) | over 1 year ago | 0 comments

30598
1
CervoMed Inc. CervoMed Reports Significant Net Loss and Increased Grant Revenue in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

30599
1
Mineralys Therapeutics, Inc. Mineralys Therapeutics Reports Increased Cash Reserves, Rising Operating Expenses, and Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

30600
1
GILEAD SCIENCES, INC. Gilead Sciences Reports Mixed Q3 Results with Increased Revenues and Declining Profitability

Via official filing (AI summary) | over 1 year ago | 0 comments